
Page#1
FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
Years ended June 30
Dollars in millions, except share and per share data  2016  2015  2014
Net sales $ 5,761  $ 5,655  $ 5,514
Cost of products sold  3,163 3,190 3,158
Gross profit  2,598 2,465 2,356 
Selling and administrative expenses  806 798 751
Advertising costs 587 523 503
Research and development costs 141 136 125
Interest expense 88 100 103 
Other (income) expense, net (7) (13) (10)
Earnings from continuing operations before income taxes 983 921 884 
Income taxes on continuing operations 335 315 305 
Earnings from continuing operations 648 606 579 
Losses from discontinued operations, net of tax  — (26) (21)
Net earnings $  648  $  580  $  558 
Net earnings (losses) per share
 Basic
  Continuing operations  $  5.01  $  4.65  $  4.47 
  Discontinued operations — (0.20) (0.16)
 Basic net earnings per share $  5.01  $  4.45  $  4.31
 Diluted
  Continuing operations $  4.92  $  4.57  $  4.39
  Discontinued operations  — (0.20) (0.16)
 Diluted net earnings per share $  4.92  $  4.37 $  4.23
Weighted average shares outstanding (in thousands)
 Basic 129,472 130,310 129,558
 Diluted  131,717  132,776  131,742
 32
  The Clorox Company 2016 Integrated Annual Report
Page#2
FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED BALANCE SHEETS
As of June 30
Dollars in millions, except share and per share data 2016  2015
ASSETS
Current assets
 Cash and cash equivalents $  401  $  382 
 Receivables, net 569 519 
 Inventories, net 443 385
 Other current assets 72 143
  Total current assets 1,485 1,429
Property, plant and equipment, net 906 918
Goodwill 1,197 1,067
Trademarks, net 657 535
Other intangible assets, net 78 50
Other assets 195 165
Total assets $  4,518  $ 4,164
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
 Notes and loans payable $  523  $  95 
 Current maturities of long-term debt — 300
 Accounts payable and accrued liabilities 1,035 979
 Income taxes payable — 31
  Total current liabilities 1,558 1,405
Long-term debt 1,797 1,796
Other liabilities 784 750
Deferred income taxes 82 95
  Total liabilities $  4,221  $ 4,046
Commitments and contingencies
 
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; 
 none issued or outstanding —  — 
Common stock: $1.00 par value; 750,000,000 shares authorized; 158,741,461 shares issued 
 as of June 30, 2016 and 2015; and 129,355,263 and 128,614,310 shares outstanding 
 as of June 30, 2016 and 2015, respectively 159 159
Additional paid-in capital 868 775
Retained earnings 2,163 1,923
Treasury shares, at cost: 29,386,198 and 30,127,151 shares 
 as of June 30, 2016 and 2015, respectively (2,323)  (2,237)
Accumulated other comprehensive net (losses) income (570) (502)
Stockholders’ equity 297 118
Total liabilities and stockholders’ equity $  4,518  $ 4,164
 34
  The Clorox Company 2016 Integrated Annual Report
Page#3
FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Years ended June 30
Dollars in millions  2016  2015  2014
Operating activities:
 Net earnings $  648  $  580  $  558 
 Deduct: Losses from discontinued operations, net of tax  — (26) (21)
 Earnings from continuing operations 648 606 579 
 Adjustments to reconcile earnings from continuing operations to net cash 
  provided by continuing operations:
 Depreciation and amortization 165 169 177 
 Stock-based compensation 45 32 36 
 Deferred income taxes 5 (16) (21)
 Settlement of interest rate forward contracts  — (25)  —
 Other 1 (17) 6 
 Changes in:
 Receivables, net (52) 6 20 
 Inventories, net (45) (25) 1 
 Other current assets 6 6 5 
 Accounts payable and accrued liabilities 57 93 (12)
 Income taxes payable (62) 29 (5)
Net cash provided by continuing operations  768 858 786 
Net cash provided by (used for) discontinued operations 10 16 (19)
Net cash provided by operations 778 874 767 
Investing activities:
 Capital expenditures  (172)  (125)  (137)
 Business acquired, net of cash acquired  (290)  —  —
 Other 32 19 —
Net cash used for investing activities from continuing operations  (430)  (106)  (137)
Net cash used for investing activities by discontinued operations  —  — (1)
Net cash used for investing activities (430)  (106)  (138)
Financing activities:
 Notes and loans payable, net 426 (48) (60)
 Long-term debt borrowings, net of issuance costs  — 495 —
 Long-term debt repayments  (300)  (575)  —
 Treasury stock purchased  (254)  (434)  (260)
 Cash dividends paid  (398)  (385)  (368)
 Issuance of common stock for employee stock plans and other 210 251 96 
Net cash used for financing activities  (316)  (696)  (592)
Effect of exchange rate changes on cash and cash equivalents (13) (19) (7)
Net increase in cash and cash equivalents 19 53 30 
Cash and cash equivalents:
 Beginning of year 382 329 299 
 End of year $  401  $  382  $  329 
Supplemental cash flow information:
 Interest paid $  79  $  104  $  76 
 Income taxes paid, net of refunds 323 236 312 
Noncash financing activities:
 Cash dividends declared and accrued, but not paid 104 99 95
 36
  The Clorox Company 2016 Integrated Annual Report